Brugada综合征
医学
危险分层
心源性猝死
心室颤动
无症状的
内科学
心脏病学
家族史
猝死
植入式心律转复除颤器
流行病学
重症监护医学
作者
Yukiko Nakano,Wataru Shimizu
出处
期刊:JACC: Asia
[Elsevier]
日期:2022-08-01
卷期号:2 (4): 412-421
被引量:12
标识
DOI:10.1016/j.jacasi.2022.03.011
摘要
Brugada syndrome (BrS) is one of the main inherited arrhythmia syndromes causing ventricular fibrillation (VF) and sudden cardiac death in young to middle-aged men, especially in Asians. The diagnosis of BrS is based on spontaneous or drug-provoked type 1 Brugada electrocardiogram. The current reliable therapy for BrS patients with VF history is the implantation of an implantable cardioverter-defibrillator. As for BrS patients without VF history, how asymptomatic BrS patients should effectively be treated is still uncertain because risk stratification of the BrS is still inadequate. Various parameters and combinations of several parameters have been reported for risk stratification of BrS. The SCN5A gene is believed to be the only gene that is responsible for BrS, and it has been reported to be useful for risk stratification. This review focuses on risk stratification of BrS patients, and focuses specifically on BrS patients of Asian descent.
科研通智能强力驱动
Strongly Powered by AbleSci AI